Ladenburg Thalmann Starts Neurobo Pharmaceuticals (NRBO) at Buy
Tweet
Share
E-mailGet Alerts NRBO Hot Sheet
Price: $2.36 --0%
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
3 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Ladenburg Thalmann initiates coverage on Neurobo Pharmaceuticals (NASDAQ: NRBO) with a Buy rating and a price target of $6.00.
For an analyst ratings summary and ratings history on Neurobo Pharmaceuticals click here. For more ratings news on Neurobo Pharmaceuticals click here.
Shares of Neurobo Pharmaceuticals closed at $1.42 yesterday.
You May Also Be Interested In
- ICICI Securities Resumes Oberoi Realty Ltd (OBER:IN) at Buy (1)
- Leerink Starts Ligand Pharma (LGND) at Outperform
- BMO Capital Resumes Snowline Gold Corp (SGD:CN) (SNWGF) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
